Age, giving birth to children or a combination of the two can have a damaging effect on women’s urinary continence or ability to have a bowel movement. Conditions like stress urinary incontinence and pelvic organ prolapse, also called pelvic floor disorder, can have dire implications for a woman’s health and quality of life.
The medical profession has yet to find a fully effective cure for these issues, although there have been treatments available for many years. Several brands of surgical mesh have also served as vaginal mesh for women, which requires surgery and extensive healing.
These surgeries can offer the potential for relief to women dealing with these frustrating symptoms. Unfortunately, for some women, transvaginal mesh surgery will result in complications that could produce even worse symptoms than the original medical condition. Those dealing with the negative consequences of a transvaginal mesh surgery may have the option of pursuing compensation from the manufacturer in certain circumstances.
To understand why mesh fails, you must understand how it works
Transvaginal mesh works by providing reinforcement where the body can no longer support itself or maintain tissue integrity. Surgeons can use surgical mesh to help reinforce a weakened vaginal wall, support the abdomen or even support the urethra or bladder.
However, for some people, the healing process after the surgery isn’t simple and straightforward. Some people will develop adhesions around the areas where the mesh touches their tissue. Other people may experience the erosion of the vaginal wall, spontaneous bleeding, painful sexual intercourse or generalized pelvic pain. In some cases, the mesh even causes tearing of the organs, and many women experience emotional trauma due to the failed medical treatment and the symptoms it creates.
The FDA no longer allows the sale or marketing of pelvic mesh
Issues with transvaginal mesh are so concerning that despite allowing their use for years, the Food and Drug Administration (FDA) has issued an order requiring the cessation of all sales of surgical mesh for pelvic or vaginal procedures.
Sadly, that action comes too late for the thousands of women negatively impacted by medical device manufacturers who did not do necessary testing and trials to determine the true long-term safety of their products for this specific application.